journal article·2025-02

A Redox‐Triggered Polymeric Nanoparticle for Disrupting Redox Homeostasis and Enhanced Ferroptosis

Yifei Li, Shangcong Han, Yi Zhao, Jianqin Yan, Kui Luo, Fashun Li, Bin He, Yong Sun, Fan Li, Yan Liang

Small· Volume 21· Issue 5
Publisher page

Abstract

Abstract Cancer cells possess an efficient redox system, enabling them to withstand oxidative damage induced by treatments, especially in hypoxia areas and ferroptosis can disrupt redox homeostasis in cancer cell. Herein, GSH‐sensitive nanoparticles are constructed that induce ferroptosis by long‐lasting GSH depletion and enhanced PDT. Carbonic anhydrase IX inhibitor, protoporphyrin IX (Por) complexed with Fe and epirubicin (EPI) are grafted to hyaluronic acid (HA) via disulfide bonds to obtain HSPFE and loaded xCT inhibitor SAS for fabricating SAS@HSPFE which is actively targeted to deep hypoxic tumor cells, and explosively releasing EPI, Por‐Fe complex and SAS due to at high GSH concentration. Specifically, SAS inhibited the GSH biosynthesis, and the generation of ROS by Por and the involvement of Fe2+ in the Fenton reaction jointly facilitates oxidative stress. Besides, Fe2+ reacted with excess H2O2 to produce O2, which continuously fuels PDT. GPX4 and SLC7A11 related to antioxidant defense are down‐regulated, while ACSL4 and TFRC promoting lipid peroxidation and ROS accumulation are up‐regulated, which enhanced ferroptosis by amplifying oxidative stress and suppressing antioxidant defense. SAS@HSPFE NPs revealed highly efficient antitumor effect in vivo study. This study provides a novel approach to cancer treatment by targeting redox imbalance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics School of Pharmacy Qingdao University Qingdao 266073 China

Department of Recuperation Medicine Qingdao Special Service Sanatorium of PLA Navy Qingdao 266071 China

Huaxi MR Research Center (HMRRC) Department of Radiology West China Hospital Sichuan University Chengdu 610041 China

National Engineering Research Center for Biomaterials Sichuan University Chengdu 610064 China

Department of Oral Implantology The Affiliated Hospital of Qingdao University Qingdao 266000 China

Funding

Youth Innovation Technology Project of Higher School in Shandong Province · Key Technology Research and Development Program of Shandong Province · Natural Science Foundation of Shandong Province

References (53)

Show source-provided references
1. 10.1016/j.drup.2004.01.00410.1016/j.drup.2004.01.004 ↗
2. 10.1016/j.canlet.2015.07.00810.1016/j.canlet.2015.07.008 ↗
3. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
4. 10.1021/jacs.2c1280910.1021/jacs.2c12809 ↗
5. 10.1016/j.redox.2020.10175310.1016/j.redox.2020.101753 ↗
6. 10.1038/s41422-019-0164-510.1038/s41422-019-0164-5 ↗
7. 10.1038/s41419-023-06144-w10.1038/s41419-023-06144-w ↗
8. 10.1073/pnas.182102211610.1073/pnas.1821022116 ↗
9. 10.1002/anie.20151003110.1002/anie.201510031 ↗
10. 10.1016/j.biomaterials.2021.12111010.1016/j.biomaterials.2021.121110 ↗
11. 10.1021/cr500419810.1021/cr5004198 ↗
12. 10.1016/j.matdes.2022.11158410.1016/j.matdes.2022.111584 ↗
13. 10.7150/thno.3286710.7150/thno.32867 ↗
14. 10.1016/j.trecan.2021.01.01310.1016/j.trecan.2021.01.013 ↗
15. 10.1016/j.cej.2023.14764510.1016/j.cej.2023.147645 ↗
16. 10.7150/thno.8785410.7150/thno.87854 ↗
17. Wang H. · Asian J. Pharm. · 2023 · 18
18. 10.1002/advs.20210099710.1002/advs.202100997 ↗
19. 10.1039/D3SC02350H10.1039/D3SC02350H ↗
20. 10.1158/0008-5472.CAN-20-164110.1158/0008-5472.CAN-20-1641 ↗
21. 10.1021/acsnano.9b0549310.1021/acsnano.9b05493 ↗
22. 10.1002/advs.20230273110.1002/advs.202302731 ↗
23. 10.1021/acsnano.3c0503410.1021/acsnano.3c05034 ↗
24. 10.1021/acsami.5b0209510.1021/acsami.5b02095 ↗
25. 10.1021/jacs.7b0239610.1021/jacs.7b02396 ↗
26. 10.1016/j.biomaterials.2023.12244210.1016/j.biomaterials.2023.122442 ↗
27. 10.1016/j.jconrel.2022.06.02210.1016/j.jconrel.2022.06.022 ↗
28. 10.1002/smll.20200170410.1002/smll.202001704 ↗
29. 10.1016/j.biomaterials.2023.12239510.1016/j.biomaterials.2023.122395 ↗
30. 10.1021/acschembio.2c0047510.1021/acschembio.2c00475 ↗
31. 10.1093/rb/rbad04810.1093/rb/rbad048 ↗
32. 10.1186/s12951-023-01953-910.1186/s12951-023-01953-9 ↗
33. 10.1002/smll.20220612410.1002/smll.202206124 ↗
34. 10.1038/s41580-019-0173-810.1038/s41580-019-0173-8 ↗
35. 10.1002/smll.20220216110.1002/smll.202202161 ↗
36. 10.1002/adma.20230971110.1002/adma.202309711 ↗
37. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
38. 10.1080/15548627.2020.181091810.1080/15548627.2020.1810918 ↗
39. 10.1021/acsnano.2c1231910.1021/acsnano.2c12319 ↗
40. 10.1016/j.devcel.2019.10.00710.1016/j.devcel.2019.10.007 ↗
41. 10.1186/s13045-020-00990-310.1186/s13045-020-00990-3 ↗
42. 10.3390/cells802015310.3390/cells8020153 ↗
43. 10.1186/s13045-023-01439-z10.1186/s13045-023-01439-z ↗
44. 10.1038/s41568-021-00411-810.1038/s41568-021-00411-8 ↗
45. 10.1038/s41586-019-1426-610.1038/s41586-019-1426-6 ↗
46. 10.1038/sj.cdd.440160110.1038/sj.cdd.4401601 ↗
47. 10.1016/j.colsurfb.2024.11387110.1016/j.colsurfb.2024.113871 ↗
48. 10.7150/ijbs.6465410.7150/ijbs.64654 ↗
49. 10.7150/thno.4188210.7150/thno.41882 ↗
50. 10.1002/adma.20190715210.1002/adma.201907152 ↗
51. 10.1016/j.jconrel.2023.06.03310.1016/j.jconrel.2023.06.033 ↗
52. 10.3390/pharmaceutics1403052710.3390/pharmaceutics14030527 ↗
53. 10.1016/j.biomaterials.2023.12244710.1016/j.biomaterials.2023.122447 ↗